
Kara Lynch, University of California, San Francisco, USA, discusses drug screening workflows using the TripleTOF® 5600 System, and contrasts experiences with traditional LC/MS/MS and LC-TOF systems. She also shares case studies that show high-resolution MS/MS methods are capable of identifying novel compounds.
